Go Pro
NYSE:CNC

Centene (CNC) Stock Price, News & Analysis

Centene logo
$67.53 +1.49 (+2.25%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$67.61 +0.09 (+0.13%)
As of 08/14/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$65.85
$67.62
50-Day Range
$60.52
$68.63
52-Week Range
$27.76
$69.36
Volume
2.27 million shs
Average Volume
5.20 million shs
Market Capitalization
$33.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.15
Consensus Rating
Hold

Company Overview

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services. These include pharmacy benefits management, behavioral health programs, care management and utilization review, provider network development, long-term services and supports, and correctional health services. The company emphasizes coordinated, value-based care models intended to improve outcomes for low-income and medically complex members, and it frequently integrates local community health initiatives and social determinants of health into its programs.

The company has expanded significantly through acquisitions and strategic partnerships to broaden its product set and geographic footprint. A notable transaction was the acquisition of WellCare Health Plans, which strengthened Centene’s presence in the Medicare Advantage and Medicaid markets. Centene also operates a number of subsidiaries and specialized business units to deliver targeted capabilities such as specialty pharmacy, behavioral health services, and managed care technology solutions.

Centene serves clients primarily across the United States and maintains operations and partnerships that support services internationally. The company is governed by an executive leadership team and board of directors responsible for strategy, regulatory relationships and operational oversight. Its focus remains on serving government-sponsored healthcare populations while expanding capabilities to address whole-person care and cost management in complex care settings.

AI Generated. May Contain Errors.

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 65% of companies evaluated by MarketBeat, and ranked 284th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 1 strong buy rating, 8 buy ratings, 9 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Centene has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 9.41% in the coming year, from $4.89 to $5.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is -6.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is -6.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.35. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.47. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    2.76% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 2.42, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 1.15%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • News Sentiment

    Centene has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Centene this week, compared to 9 articles on an average week.
  • Search Interest

    24 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 140% compared to the previous 30 days.
  • MarketBeat Follows

    22 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 1,000% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.37% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

Centene (CNC) Stock Still Looks Like A Bargain As Shares Jumped 145%
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Argus Upgrades Centene (NYSE:CNC) to "Buy"
Analysts Set Centene Corporation (NYSE:CNC) Price Target at $68.58
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $41.18 on January 1st, 2026. Since then, CNC stock has increased by 64.0% and is now trading at $67.5260.

Centene Corporation (NYSE:CNC) issued its quarterly earnings data on Tuesday, July, 28th. The company reported $2.51 EPS for the quarter, beating the consensus estimate of $1.09 by $1.42. Centene's quarterly revenue was up 9.9% compared to the same quarter last year.
Read the conference call transcript
.

Shares of Centene split before market open on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were issued to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others.

Top institutional shareholders of Centene include BlackRock Inc. (8.39%), Deutsche Bank AG (0.81%), Legal & General Group Plc (0.77%) and Assenagon Asset Management S.A. (0.75%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
7/28/2026
Today
8/15/2026
Next Earnings (Estimated)
10/27/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Managed Healthcare
Current Symbol
NYSE:CNC
CIK
1071739
Employees
61,100
Year Founded
1984

Price Target and Rating

High Price Target
$80.00
Low Price Target
$40.00
Potential Upside/Downside
+2.4%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
($10.44)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.81
P/E Growth
0.35
Net Income
-$6.67 billion
Net Margins
-2.51%
Pretax Margin
-2.28%
Return on Equity
12.12%
Return on Assets
3.20%

Debt

Debt-to-Equity Ratio
0.71
Current Ratio
1.15
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$194.78 billion
Price / Sales
0.17
Cash Flow
$4.79 per share
Price / Cash Flow
14.10
Book Value
$45.82 per share
Price / Book
1.47

Miscellaneous

Outstanding Shares
493,990,000
Free Float
492,167,000
Market Cap
$33.36 billion
Optionable
Optionable
Beta
1.08

Social Links

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:CNC) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners